Zobrazeno 1 - 10
of 24
pro vyhledávání: '"S F, Kowalsky"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:1153-1156
Many drugs exhibit altered pharmacokinetic parameters in burn patients. We prospectively evaluated the pharmacokinetics of ciprofloxacin in eight burn patients with active infections. Each patient received a 400-mg dose of ciprofloxacin intravenously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674adda58f8a2d71d087810f0f5fd66e
https://doi.org/10.1128/aac.40.5.1153
https://doi.org/10.1128/aac.40.5.1153
Autor:
S F Kowalsky, Abdollah Iravani, D H Sikes, J McCarty, A Heyd, R L Tosiello, E P Whalen, Alan D. Tice, Harry A. Gallis, Thomas Nolen
Publikováno v:
Archives of Internal Medicine. 155:485-494
Background Three studies were undertaken to determine the minimum effective dosing regimen of ciprofloxacin for the treatment of acute, symptomatic, uncomplicated lower urinary tract infection. Methods All studies were multicenter, prospective, rando
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8d3dc38047b78807999cc2a62296644
https://doi.org/10.1001/archinte.155.5.485
https://doi.org/10.1001/archinte.155.5.485
Autor:
S F Kowalsky, D M Dixon
Publikováno v:
American Journal of Health-System Pharmacy. 48:827-835
The chemistry, activity, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and administration of fluconazole are reviewed. Fluconazole is a triazole antifungal agent labeled for use in the treatment of oropharyngeal and esophag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6eb5fa6108657f397916151a83cd57f1
https://doi.org/10.1093/ajhp/48.4.827
https://doi.org/10.1093/ajhp/48.4.827
Publikováno v:
The Journal of antimicrobial chemotherapy. 43
The study was undertaken to compare the safety and efficacy of twice-daily ciprofloxacin for 3 days with standard 7 day therapy with either co-trimoxazole or nitrofurantoin in the treatment of women with acute, uncomplicated urinary tract infections
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5df30d167030472c22e03c73e5cacbfe
https://pubmed.ncbi.nlm.nih.gov/10225575
https://pubmed.ncbi.nlm.nih.gov/10225575
Publikováno v:
The Journal of antimicrobial chemotherapy. 43
To determine the efficacy and safety of single-dose oral ciprofloxacin prophylaxis for the prevention of post-operative bacteriuria following transurethral resection of the prostate or bladder tumour, a prospective, randomized, double-blind, placebo-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dcf6ebce9c8ef190cc137ac806355012
https://pubmed.ncbi.nlm.nih.gov/10225576
https://pubmed.ncbi.nlm.nih.gov/10225576
Autor:
S F, Kowalsky
Publikováno v:
Pharmacy practice management quarterly. 16(2)
Drug development requires the cooperation and efforts of industry and investigators. If the process is to be successful (i.e., FDA approval), then both industry and investigators must be committed and clearly understand the goals and objectives of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d21310422aacbd66389710b92cc460f
https://pubmed.ncbi.nlm.nih.gov/10161605
https://pubmed.ncbi.nlm.nih.gov/10161605
Autor:
A, Iravani, A D, Tice, J, McCarty, D H, Sikes, T, Nolen, H A, Gallis, E P, Whalen, R L, Tosiello, A, Heyd, S F, Kowalsky
Publikováno v:
Archives of internal medicine. 155(5)
Three studies were undertaken to determine the minimum effective dosing regimen of ciprofloxacin for the treatment of acute, symptomatic, uncomplicated lower urinary tract infection.All studies were multicenter, prospective, randomized, double-blind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db3128d3426656477836da20ae0d0bc5
https://pubmed.ncbi.nlm.nih.gov/8526690
https://pubmed.ncbi.nlm.nih.gov/8526690
Publikováno v:
Clinical nephrology. 39(1)
The pharmacokinetics of a single, oral dose of 750 mg of ciprofloxacin were studied in 35 subjects with various degrees of renal function (Group 1, Clcror = 80 ml/min; Group II, Clcr 50-79 ml/min; Group III, Clcr 10-49 ml/min) and on hemodialysis (HD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8e78219147c54b46c870f8ac6975778d
https://pubmed.ncbi.nlm.nih.gov/8428409
https://pubmed.ncbi.nlm.nih.gov/8428409
Publikováno v:
Clinical pharmacy. 11(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f98d66ee4b1310b248461d9d6ae99f0
https://pubmed.ncbi.nlm.nih.gov/1316254
https://pubmed.ncbi.nlm.nih.gov/1316254
Publikováno v:
Hospital formulary. 26(9)
In this 30-hospital survey, data on usage, adverse drug reaction (ADR) rates, and drug interactions (DI) of the H2-receptor antagonists (H2RA) cimetidine, ranitidine, and famotidine were analyzed. Approximately 8% (1,768 patients) admitted to partici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34bb7c8752e2874bfaada902c183b893
https://pubmed.ncbi.nlm.nih.gov/10114004
https://pubmed.ncbi.nlm.nih.gov/10114004